COLD-ADAPTED LIVE ATTENUATED VIRULENCE FACTOR-REMOVED VACCINE SUITABLE FOR MUCOSAL DELIVERY Russian patent published in 2022 - IPC A61K39/145 

Abstract RU 2770860 C2

FIELD: biotechnology.

SUBSTANCE: there are presented compositions and methods for preparing a live attenuated influenza vaccine suitable for nasal administration. This vaccine employs a cold-adapted influenza virus which does not contain a virulence factor, containing mutations providing the ability to replicate, sufficient for vaccine production.

EFFECT: vaccines obtained using said method provide significant cross-protection against strains not used for vaccination; said vaccine is safe for children under 2 years old and adults over 49 years old; besides, said cold-adapted virus with a deleted virulence factor can be adapted in order to obtain immunity from causative agents of diseases other than influenza.

9 cl, 12 dwg

Similar patents RU2770860C2

Title Year Author Number
MINUS-CHAIN-CONTAINING ATTENUATED VIRUSES WITH CHANGED ANTAGONISTIC ACTIVITY AS REGARDS FOR INTERFERON FOR APPLYING AS VACCINES AND PHARMACEUTICAL SUBSTANCES 1999
  • Palez Piter
  • Garsia-Sastre Adol'Fo
  • Master Tomas
RU2236252C2
RECOMBINANT INFLUENZA VIRUS STRAIN A/PR8/HK-NS80E85A, EXPRESSING FRAGMENTS OF ESAT-6 AND AG85A MYCOBACTERIUM TUBERCULOSIS ANTIGENS, TO OBTAIN TUBERCULOSIS VECTORED VACCINE 2018
  • Pulkina Anastasiya Aleksandrovna
  • Sergeeva Mariya Valerevna
  • Tsybalova Lyudmila Markovna
  • Stukova Marina Anatolevna
RU2678175C1
RECOMBINANT INFLUENZA VIRUS A 2001
  • Ferko Boris
  • Egorov Andrej Jur'Evich
  • Foglauehr Regina
RU2280690C2
RECOMBINANT STRAIN OF INFLUENZA VIRUS A/PR8-NS124-TB10_4-2A-HSPX AND METHOD FOR SPECIFIC PREVENTION OF PULMONARY TUBERCULOSIS USING MUCOSAL VACCINE BASED THEREON 2019
  • Stukova Marina Anatolevna
  • Vinogradova Tatyana Ivanovna
  • Zabolotnykh Nataliya Vyacheslavovna
  • Sergeeva Mariya Valerevna
  • Buzitskaya Zhanna Valerevna
RU2726106C1
ATTENUATED INFLUENZA VECTORS FOR THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AS WELL AS FOR CANCER TREATMENT 2015
  • Egorov Andrej Yurevich
  • Ferko Boris
  • Krokhin Artem Aleksandrovich
  • Romanova Yuliya Romanovna
RU2628690C2
RECOMBINANT INFLUENZA VIRUS INTENDED FOR THE PREVENTION OF COVID-19 AND INFLUENZA, METHOD OF ITS PRODUCTION AND USE 2022
  • Sergeeva Mariya Valerevna
  • Elshin Nikita Dmitrievich
  • Romanovskaya-Romanko Ekaterina Andreevna
  • Stukova Marina Anatolevna
  • Lioznov Dmitrij Anatolevich
RU2802058C1
METHOD FOR OBTAINING ATTENUATED STRAINS OF INFLUENZA A VIRUS - CANDIDATES FOR LIVE INFLUENZA VACCINES 2017
  • Markushin Stanislav Georgievich
  • Kost Vladimir Yurevich
  • Mintaev Ramil Rafailovich
  • Rtishchev Artem Andreevich
  • Akopova Irina Ivanovna
  • Koptyaeva Irina Borisovna
RU2670514C1
REASSORTANT A/17/NEW CALEDONIA/99/79(H1N1) INFLUENZA VIRUS STRAIN FOR PRODUCING LIVE INFLUENZA INTRANASAL VACCINE 2011
  • Desheva Julija Andreevna
  • Rudenko Larisa Georgievna
  • Aleksandrova Galina Ibragimovna
RU2464310C1
ATTENUATED GRIPPOSE VECTOR AND MUCOSAL UNIVERSAL GRIPPOSE VACCINE ON ITS BASIS 2016
  • Egorov Andrej Yurevich
  • Ferko Boris
  • Krokhin Artem Aleksandrovich
  • Romanova Yuliya Romanovna
RU2660562C2
INFLUENZA VIRUS STRAIN A/Hongkong/1/68/162/35 (H3N2) - UNIVERSAL DONOR OF INTERNAL GENES FOR REASSORTANTS, AND REASSORTANT STRAINS A/SPB/GK/09 (H1N1) AND A/HK/Astana/6:2/2010 (H5N1) PREPARED THEREOF 2011
  • Tsybalova Ljudmila Markovna
  • Gorev Nikolaj Efremovich
  • Repko Irina Anatol'Evna
  • Potapchuk Marina Valentinovna
  • Sergeeva Marija Valer'Evna
  • Kiselev Oleg Ivanovich
RU2511431C2

RU 2 770 860 C2

Authors

Chen, Khonlin

Chzhen, Min

Van, Pui

Lau, Dzhonson Iu-Nam

Eun, Kvok Yun

Dates

2022-04-22Published

2017-04-18Filed